Cardiff Lexington signs LOI to buy multi-state musculoskeletal healthcare platform for up to $104 million
Bitget2026/09/24 12:00- Cardiff Lexington entered an LOI to acquire a multi-location musculoskeletal healthcare platform operating in multiple states.
- Purchase price consideration up to USD 104 million, including USD 30 million cash at closing and USD 10 million unsecured notes due in two years.
- Sellers would receive preferred equity valued to equal 35% of fully diluted equity post-closing, with potential conversion above USD 120 million valuation.
- Earnout of up to USD 12 million in common stock tied to EBITDA thresholds for 2027, 2028, 2029.
- Target closing date set for Nov. 16, 2026, subject to due diligence, financing, and definitive agreements.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
Crypto prices
More
